Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists

Journal of Neuroscience

Volumn 33, Issue 32, 2013, Pages 13042-13052

  Yu, Qing ^a,c   Chang, Qing ^c   Liu, Xia ^c   Wang, Yunfeng ^b   Li, Huawei ^b   Gong, Shusheng ^a   Ye, Keqiang ^c   Lin, Xi ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDROXYFLAVONE; 7,8,3 TRIHYDROXYFLAVONE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CONNEXIN 26; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; CELL DENSITY; CELL SURVIVAL; COCHLEA; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED BRAIN STEM AUDITORY RESPONSE; HAIR CELL; HISTOLOGY; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPIRAL GANGLION; WESTERN BLOTTING;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCHLEA; CONNEXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FLAVONES; GENTAMICINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURITES; NEURONS; PHOSPHORYLATION; RECEPTOR, TRKB; SPIRAL GANGLION; TUBULIN;

EID: 84881130819     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0854-13.2013     Document Type: Article

References (60)

1. Ahmad S, Tang W, Chang Q, Qu Y, Hibshman J, Li Y, Söhl G, Willecke K, Chen P, Lin X (2007) Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A 104:1337-1341. CrossRef Medline
2. Barclay M, Ryan AF, Housley GD (2011) Type I vs type II spiral ganglion neurons exhibit differential survival and neuritogenesis during cochlear development. Neural Dev 6:33-48. CrossRef Medline
3. Bishop AC, Ubersax JA, Petsch DT, Matheos DP, Gray NS, Blethrow J, Shimizu E, Tsien JZ, Schultz PG, Rose MD, Wood JL, Morgan DO, Shokat KM (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407:395-401. CrossRef Medline
4. Blugeot A, Rivat C, Bouvier E, Molet J, Mouchard A, Zeau B, Bernard C, Benoliel JJ, Becker C (2011) Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 31:12889-12899. CrossRef Medline
5. Chang Q, Tang W, Ahmad S, Zhou B, Lin X (2008) Gap junction mediated intercellular metabolite transfer in the cochlea is compromised in connexin30 null mice. PLoS One 3:e4088. CrossRef Medline
6. Chen X, Ye H, Kuruvilla R, Ramanan N, Scangos KW, Zhang C, Johnson NM, England PM, Shokat KM, Ginty DD (2005) A chemical-genetic approach to studying neurotrophin signaling. Neuron 46:13-21. CrossRef Medline
7. Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ (2010) Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A 107:2675-2680. CrossRef Medline
8. Clopton BM, Spelman FA, Miller JM (1980) Estimates of essential neural elements for stimulation through a cochlear prosthesis. Ann Otol Rhinol Laryngol Suppl 89:5-7. Medline
9. Dallos P, Popper AN, Fay RR (1996) Springer handbook of auditory research: the cochlea. New York: Springer.
10. Devi L, Ohno M (2012) 7,8-Dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 37:434-444. CrossRef Medline
11. Dodson HC, Mohuiddin A (2000) Response of spiral ganglion neurones to cochlear hair cell destruction in the guinea pig. J Neurocytol 29:525-537. CrossRef Medline
12. Ernfors P, Van De Water T, Loring J, Jaenisch R (1995) Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14:1153-1164. CrossRef Medline
13. Ernfors P, Duan ML, ElShamy WM, Canlon B (1996) Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat Med 2:463-467. CrossRef Medline
14. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF (1994) Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 369:658-661. CrossRef Medline
15. Fritzsch B, Pirvola U, Ylikoski J (1999) Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res 295:369-382. CrossRef Medline
16. Gillespie LN, Shepherd RK (2005) Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. Eur J Neurosci 22:2123-2133. CrossRef Medline
17. Gillespie LN, Clark GM, Bartlett PF, Marzella PL (2003) BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J Neurosci Res 71:785-790. CrossRef Medline
18. Guillery RW (2002) On counting and counting errors. J Comp Neurol 447: 1-7. CrossRef Medline
19. Hardie NA, Shepherd RK (1999) Sensorineural hearing loss during development: morphological and physiological response of the cochlea and auditory brainstem. Hear Res 128:147-165. CrossRef Medline
20. 2+]i within a set range. J Neurosci 17:1959-1970. Medline
21. Hudspeth AJ (1997) How hearing happens. Neuron 19:947-950. CrossRef Medline
22. Incesulu A, Nadol JB Jr (1998) Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 107:906-911. Medline
23. Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci U S A 107:2687-2692. CrossRef Medline
24. Johnson RA, Lam M, Punzo AM, Li H, Lin BR, Ye K, Mitchell GS, Chang Q (2012) 7,8-dihydroxyflavone (7,8-DHF) exhibits therapeutic efficacy in a mouse model of Rett syndrome. J Appl Physiol 112:704-710. Medline
25. Jyung RW, Miller JM, Cannon SC (1989) Evaluation of eighth nerve integrity by the electrically evoked middle latency response. Otolaryngol Head Neck Surg 101:670-682. Medline
26. Kawamoto K, Oh SH, Kanzaki S, Brown N, Raphael Y (2001) The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 4:575-585. CrossRef Medline
27. Leake PA, Hradek GT (1988) Cochlear pathology of long term neomycin induced deafness in cats. Hear Res 33:11-33. CrossRef Medline
28. Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G (1994) Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport 5:865-868. CrossRef Medline
29. Lewin GR, Barde YA (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317. CrossRef Medline
30. Linthicum FH Jr, Fayad JN (2009) Spiral ganglion cell loss is unrelated to segmental cochlear sensory system degeneration in humans. Otol Neurotol 30:418-422. CrossRef Medline
31. Liu X, Chan CB, Jang SW, Pradoldej S, Huang J, He K, Phun LH, France S, Xiao G, Jia Y, Luo HR, Ye K (2010) A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem 53:8274-8286. CrossRef Medline
32. Liu X, Chan CB, Qi Q, Xiao G, Luo HR, He X, Ye K (2012) Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression. J Med Chem 55:8524-8537. CrossRef Medline
33. Malgrange B, Lefebvre P, Van de Water TR, Staecker H, Moonen G (1996) Effects of neurotrophins on early auditory neurones in cell culture. Neuroreport 7:913-917. CrossRef Medline
34. Maricich SM, Xia A, Mathes EL, Wang VY, Oghalai JS, Fritzsch B, Zoghbi HY (2009) Atoh1-lineal neurons are required for hearing and for the survival of neurons in the spiral ganglion and brainstem accessory auditory nuclei. J Neurosci 29:11123-11133. CrossRef Medline
35. Middlemas DS, Meisenhelder J, Hunter T (1994) Identification of TrkB autophosphorylation sites and evidence that phospholipase C-gamma 1 is a substrate of the TrkB receptor. J Biol Chem 269:5458-5466. Medline
36. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA (1997) Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 15:631-643. CrossRef Medline
37. Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV (2000) A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201-206. CrossRef Medline
38. Otte J, Schunknecht HF, Kerr AG (1978) Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation. Laryngoscope 88:1231-1246. CrossRef Medline
39. Pan N, Jahan I, Kersigo J, Kopecky B, Santi P, Johnson S, Schmitz H, Fritzsch B (2011) Conditional deletion of Atoh1 using Pax2-Cre results in viable mice without differentiated cochlear hair cells that have lost most of the organ of Corti. Hear Res 275:66-80. CrossRef Medline
40. Payá M, Ferrandiz ML, Sanz MJ, Alcaraz MJ (1993) Effects of phenolic compounds on bromobenzene-mediated hepatotoxicity in mice. Xenobiotica 23:327-333. CrossRef Medline
41. Pettingill LN, Richardson RT, Wise AK, O'Leary SJ, Shepherd RK (2007) Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system. IEEE Trans Biomed Eng 54:1138-1148. CrossRef Medline
42. Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, Raphael Y (2007) Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228:180-187. CrossRef Medline
43. Rubel EW, Fritzsch B (2002) Auditory system development: primary auditory neurons and their targets. Annu Rev Neurosci 25:51-101. CrossRef Medline
44. Saragovi HU, Gehring K (2000) Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol Sci 21:93-98. CrossRef Medline
45. Schecterson LC, Bothwell M (1994) Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear. Hear Res 73:92-100. CrossRef Medline
46. Shepherd RK, Coco A, Epp SB (2008) Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear Res 242:100-109. CrossRef Medline
47. Shibata SB, Budenz CL, Bowling SA, Pfingst BE, Raphael Y (2011) Nerve maintenance and regeneration in the damaged cochlea. Hear Res 281:56-64. CrossRef Medline
48. Shinohara T, Bredberg G, Ulfendahl M, Pyykkö I, Olivius NP, Kaksonen R, Lindström B, Altschuler R, Miller JM (2002) Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 99:1657-1660. CrossRef Medline
49. Skinner MW, Ketten DR, Holden LK, Harding GW, Smith PG, Gates GA, Neely JG, Kletzker GR, Brunsden B, Blocker B (2002) CT-derived estimation of cochlear morphology and electrode array position in relation to word recognition in Nucleus-22 recipients. J Assoc Res Otolaryngol 3:332-350. CrossRef Medline
50. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR (1996) NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 7:889-894. CrossRef Medline
51. Staecker H, Gabaizadeh R, Federoff H, Van De Water TR (1998) Brainderived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol Head Neck Surg 119:7-13. CrossRef Medline
52. Sugawara M, Corfas G, Liberman MC (2005) Influence of supporting cells on neuronal degeneration after hair cell loss. J Assoc Res Otolaryngol 6:136-147. CrossRef Medline
53. 2+ signaling than homomeric counterparts. Am J Physiol Cell Physiol 288:C613-C623. CrossRef Medline
54. Sun Y, Tang W, Chang Q, Wang Y, Kong W, Lin X (2009) Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol 516:569-579. CrossRef Medline
55. Tasdemir D, Kaiser M, Brun R, Yardley V, Schmidt TJ, Tosun F, Ruedi P (2006) Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 50:1352-1364. CrossRef Medline
56. Thoenen H, Sendtner M (2002) Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci [Suppl] 5:1046-1050. CrossRef Medline
57. Wang Y, Chang Q, Tang W, Sun Y, Zhou B, Li H, Lin X (2009) Targeted connexin26 ablation arrests postnatal development of the organ of Corti. Biochem Biophys Res Commun 385:33-37. CrossRef Medline
58. Ylikoski J, Pirvola U, Moshnyakov M, Palgi J, Arumäe U, Saarma M (1993) Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res 65:69-78. CrossRef Medline
59. Yu Q, Chang Q, Liu X, Gong S, Ye K, Lin X (2012) 7,8,3-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivo. Biochem Biophys Res Commun 422:387-392. CrossRef Medline
60. Zheng JL, Gao WQ (1996) Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur J Neurosci 8:1897-1905. CrossRef Medline